Finance

Lists
ICY:FRA
Incyte Corp
100,05 €
-1,09%
(-1,10) 1D
9 ოქტ, 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ICY...
Open
100,05 €
High
100,05 €
Low
100,05 €
Mkt. cap
22,86 მლრდ.
Avg. vol.
34,00
Volume
0,00
52-wk high
115,40 €
52-wk low
72,28 €
No. of employees
3 ათ.
Open
100,05 €
High
100,05 €
Low
100,05 €
Mkt. cap
22,86 მლრდ.
Avg. vol.
34,00
Volume
0,00
52-wk high
115,40 €
52-wk low
72,28 €
No. of employees
3 ათ.
News stories
From web sources and news partners
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2,84 ათ.
Founded2002
Headquartersუილმინგტონი, დელავერის შტატი, ამერიკის შეერთებული შტატები
Sector-
Websiteincyte.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,37 მლრდ.
1,51 მლრდ.
1,27 მლრდ.
1,67 მლრდ.
Cost of goods sold
605,58 მლნ.
732,55 მლნ.
620,43 მლნ.
621,91 მლნ.
Cost of revenue
605,58 მლნ.
732,55 მლნ.
620,43 მლნ.
621,91 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
328,29 მლნ.
388,96 მლნ.
327,06 მლნ.
350,72 მლნ.
Operating expense
328,29 მლნ.
388,96 მლნ.
327,06 მლნ.
350,72 მლნ.
Total operating expenses
933,87 მლნ.
1,12 მლრდ.
947,49 მლნ.
972,63 მლნ.
Operating income
432,11 მლნ.
385,32 მლნ.
325,19 მლნ.
701,41 მლნ.
Other non operating income
3,25 მლნ.
4,22 მლნ.
1,75 მლნ.
5,26 მლნ.
EBT including unusual items
482,31 მლნ.
389,94 მლნ.
343,60 მლნ.
751,51 მლნ.
EBT excluding unusual items
461,55 მლნ.
419,71 მლნ.
360,06 მლნ.
744,21 მლნ.
Income tax expense
58,14 მლნ.
90,66 მლნ.
40,27 მლნ.
165,91 მლნ.
Effective tax rate
12,05%
23,25%
11,72%
22,08%
Other operating expenses
-
-
-
-
Net income
424,17 მლნ.
299,28 მლნ.
303,33 მლნ.
585,60 მლნ.
Net profit margin
31,05%
19,86%
23,83%
34,98%
Earnings per share
2,26
1,80
1,81
3,09
Interest and investment income
26,78 მლნ.
30,75 მლნ.
33,69 მლნ.
38,12 მლნ.
Interest expense
-592,00 ათ.
-582,00 ათ.
-569,00 ათ.
-582,00 ათ.
Net interest expenses
26,19 მლნ.
30,17 მლნ.
33,12 მლნ.
37,54 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
456,13 მლნ.
409,30 მლნ.
348,99 მლნ.
727,89 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები